|

Depression Clinical Trials in Memphis, TN

13 recruiting studies within 50 miles

Phase
Trial Phase Dist.
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Phase 3<1 mi
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderPhase 3<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Phase 3<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501Phase 3<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderPhase 2<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Phase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
Pharmacy-led Transitions of Care Intervention to Improve Medication AdherenceN/A<1 mi
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in PrisonsN/A8 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.